HomeGreater Than Icon
3B Blackbio DX LtdGreater Than Icon
3B Blackbio DX Ltd Financials
Company Logo

3B Blackbio DX Ltd Financial Statement

3B Blackbio DX Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue21.18
Operating Expense7.17
Net Profit10.73
Net Profit Margin50.66
Earning Per Share12.53
EBIDTA14.02
Effective Tax Rate21.83

3B Blackbio DX Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual70.72
Operating Expenses Annual35.62
Operating Profit Annual47.43
Interest Annual0.11
Depreciation0.87
Net Profit Annual34.21
Tax Annual12.23

3B Blackbio DX Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning50.35
Cash Flow from Operations28.47
Cash Flow from Investing-20.32
Cash Flow from Financing-3.62
Cash Flow at the End54.88

3B Blackbio DX Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)67.05
PBIT Margin (%)65.82
PBT Margin (%)-532.57
Net PROFIT Margin (%)48.37
Return On Networth / Equity (%)16.14
Return On Networth /Employed (%)21.82
Return On Assets (%)15.96
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)0.33

3B Blackbio DX Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual6.53
Total Current Assets Annual115.59
Non Current Assets Annual134.23
Total Shareholders Funds Annual227.78
Total Assets Annual249.82

3B Blackbio DX Ltd Earning Calls

EPS (INR)

Expected

12.99

Reported

13.19

Surprise

1.54%

Mar 2024

EPS beaten by 1.54%

Dec 2023

EPS beaten by -0.87%

Sep 2023

EPS beaten by -2.36%

Get Your FAQs Right

As of Nov 5, 2024, 3B Blackbio DX Ltd has a market capitalization of 660.52 Cr. Value Research classifies it as a Small-Cap company.
Yes, 3B Blackbio DX Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , 3B Blackbio DX Ltd recorded a total revenue of approximately 70.72 Cr marking a significant milestone in the company's financial performance.
3B Blackbio DX Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.8% annually, respectively..
3B Blackbio DX Ltd's current PE ratio is 19.31.
3B Blackbio DX Ltd's ROCE averaged 23.7% from the FY ending March 2022 to 2024, with a median of 20.4%. It peaked at 32.4% in March 2022, reflecting strong capital efficiency over the period..
3B Blackbio DX Ltd's latest EBIT is Rs. 46.55 Cr, surpassing the average EBIT of Rs. 30.39 Cr over the 5 years..